Buy & Sell T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) – T-Rex 2X Inverse MSTR Daily Target ETF Price Today
Aura AI Summary
Key Stats
- -Market Cap
- Leveraged / InverseSector
- -68.72%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 33% Buy | 67% SellTrading Activity
- 3 daysTypical Hold Time
Over the past 52 weeks, T-Rex 2X Inverse MSTR Daily Target ETF has traded between a low of $3.12 and a high of $27.92, highlighting its annual price range. Over the past three months, T-Rex 2X Inverse MSTR Daily Target ETF has recorded a drawdown of -68.72%, reflecting recent price volatility. On average, investors hold T-Rex 2X Inverse MSTR Daily Target ETF for approximately 3 days, indicating typical investor behavior on the platform.
About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Most Recent News
Over 100 drugs in clinical trials aim to transform age-related macular degeneration treatment by 2026
DelveInsight's 2026 report reveals more than 100 drugs in development for age-related macular degeneration (AMD), involving over 90 companies globally. These therapies include novel mechanisms like gene therapy, mitochondrial stabilization, and VEGF ...

Cell and gene therapy CDMO market set to grow at 24% CAGR, reaching $57.1B by 2034.
The cell and gene therapy contract development and manufacturing organization (CDMO) market is projected to grow at a compound annual growth rate (CAGR) of approximately 24% from 2026 to 2034, reaching a market size of $57.1 billion by 2034. Growth i...

Polymeric biomaterials market to hit $267B by 2034, driven by regenerative medicine and healthcare growth.
The global polymeric biomaterials market, valued at $69.55 billion in 2024, is projected to grow at a CAGR of 15.86% to reach $267.25 billion by 2034. Growth is fueled by increasing demand in regenerative medicine, orthopedics, and wound care, with A...
